CPhI Announces US-Market Report at InformEx - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Announces US-Market Report at InformEx


CPhI Worldwide announced the launch of the CPhI Pharma InsightsUSA market report, a joint venture with InformEx, which will provide European perspectives on the accessibility, growth, and export market in the United States. The report is designed to encourage and increase trade harmonization between the two major pharma economies of the world, the sponsors say.

The US country report, which will be distributed in July 2014, follows the launch of the CPhI annual report (released at CPhI Worldwide, Frankfurt, October 2013). The new report, which analyzes current and future trends across the US pharma landscape, will feature expert opinion from Europe’s leading companies, contrasted with US internal perceptions to provide a holistic view of the major trade flows within the region, according to report sponsors.

The report will examine the areas in which European companies are looking to work with US counterparts, import into the US and, domestic and export manufacturing across pharma’s fine, specialty, and custom chemicals market.

Following last year’s report, which covered the global industry, CPhI will now examine trends within specific leading pharma economies.

Source: CPhI

 

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here